So, you would be forgiven for missing the untimely demise of the Health Care Rewards to Achieve Improved Outcomes program. By federal standards, it represents a small amount: 0.0014 percent of last ...
The year started strong for Jazz Pharmaceuticals (JAZZ) with a Q4 2024 revenue beat and the company guiding 2025 revenues just slightly below the analyst consensus. However, the stock is down 22% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results